SOLV vs. ELV

Last updated Apr 1, 2026

Compare and contrast key facts about Solventum Corp (SOLV) and Elevance Health Inc (ELV).

Performance

SOLV vs. ELV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Solventum Corp (SOLV) and Elevance Health Inc (ELV). The values are adjusted to include any dividend payments, if applicable.

SOLV vs. ELV - Yearly Performance Comparison

	2026 (YTD)	2025	2024
SOLV Solventum Corp	-17.59%	19.95%	-17.43%
ELV Elevance Health Inc	-15.97%	-3.14%	-27.95%

Fundamentals

Market Cap SOLV : $11.45B ELV : $64.93B
EPS SOLV : $8.88 ELV : $25.22
PE Ratio SOLV : 7.36 ELV : 11.61
PS Ratio SOLV : 1.38 ELV : 0.33
PB Ratio SOLV : 2.27 ELV : 1.48
Total Revenue (TTM) SOLV : $8.33B ELV : $198.69B
Gross Profit (TTM) SOLV : $4.45B ELV : $111.58B
EBITDA (TTM) SOLV : $2.81B ELV : $9.57B

Returns By Period

In the year-to-date period, SOLV achieves a -17.59% return, which is significantly lower than ELV's -15.97% return.

SOLV

• 1D: 2.92%
• 1M: -11.99%
• YTD: -17.59%
• 6M: -10.55%
• 1Y: -14.12%
• 3Y*: —
• 5Y*: —
• 10Y*: —

ELV

• 1D: 2.80%
• 1M: -7.95%
• YTD: -15.97%
• 6M: -8.37%
• 1Y: -31.26%
• 3Y*: -12.58%
• 5Y*: -2.35%
• 10Y*: 9.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SOLV vs. ELV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SOLV

SOLV Risk / Return Rank: 21
SOLV Sharpe Ratio Rank: 21
SOLV Sortino Ratio Rank: 20
SOLV Omega Ratio Rank: 21
SOLV Calmar Ratio Rank: 26
SOLV Martin Ratio Rank: 17

ELV

ELV Risk / Return Rank: 13
ELV Sharpe Ratio Rank: 10
ELV Sortino Ratio Rank: 13
ELV Omega Ratio Rank: 12
ELV Calmar Ratio Rank: 14
ELV Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SOLV vs. ELV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Solventum Corp (SOLV) and Elevance Health Inc (ELV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SOLV	ELV	Difference
Sharpe ratio Return per unit of total volatility	-0.45	-0.78	+0.33
Sortino ratio Return per unit of downside risk	-0.45	-0.88	+0.42
Omega ratio Gain probability vs. loss probability	0.94	0.87	+0.07
Calmar ratio Return relative to maximum drawdown	-0.47	-0.79	+0.32
Martin ratio Return relative to average drawdown	-1.23	-1.24	0.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SOLV vs. ELV - Sharpe Ratio Comparison

The current SOLV Sharpe Ratio is -0.45, which is higher than the ELV Sharpe Ratio of -0.78. The chart below compares the historical Sharpe Ratios of SOLV and ELV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SOLV	ELV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.45	-0.78	+0.33
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.08	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.29	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.30	0.41	-0.71

Correlation

The correlation between SOLV and ELV is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SOLV vs. ELV - Dividend Comparison

SOLV has not paid dividends to shareholders, while ELV's dividend yield for the trailing twelve months is around 2.34%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SOLV Solventum Corp	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ELV Elevance Health Inc	2.34%	1.95%	1.77%	1.26%	1.00%	0.98%	1.18%	1.06%	1.14%	1.20%	1.81%	1.79%

Drawdowns

SOLV vs. ELV - Drawdown Comparison

The maximum SOLV drawdown since its inception was -39.97%, smaller than the maximum ELV drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for SOLV and ELV.

Drawdown Indicators

	SOLV	ELV	Difference
Max Drawdown Largest peak-to-trough decline	-39.97%	-67.19%	+27.22%
Max Drawdown (1Y) Largest decline over 1 year	-27.14%	-39.06%	+11.92%
Max Drawdown (5Y) Largest decline over 5 years	—	-50.38%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-50.38%	—
Current Drawdown Current decline from peak	-24.19%	-46.22%	+22.03%
Average Drawdown Average peak-to-trough decline	-15.29%	-15.15%	-0.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.24%	24.89%	-14.65%

Volatility

SOLV vs. ELV - Volatility Comparison

The current volatility for Solventum Corp (SOLV) is 7.84%, while Elevance Health Inc (ELV) has a volatility of 8.34%. This indicates that SOLV experiences smaller price fluctuations and is considered to be less risky than ELV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SOLV	ELV	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.84%	8.34%	-0.50%
Volatility (6M) Calculated over the trailing 6-month period	20.74%	27.00%	-6.26%
Volatility (1Y) Calculated over the trailing 1-year period	31.74%	40.26%	-8.52%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.26%	28.50%	+3.76%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.26%	30.70%	+1.56%

Financials

SOLV vs. ELV - Profitability Comparison

The chart below illustrates the profitability comparison between Solventum Corp and Elevance Health Inc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SOLV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Solventum Corp reported a gross profit of 985.00M and revenue of 2.00B. Therefore, the gross margin over that period was 49.3%.

ELV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Elevance Health Inc reported a gross profit of 5.72B and revenue of 49.31B. Therefore, the gross margin over that period was 11.6%.

SOLV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Solventum Corp reported an operating income of 1.68B and revenue of 2.00B, resulting in an operating margin of 84.0%.

ELV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Elevance Health Inc reported an operating income of 145.00M and revenue of 49.31B, resulting in an operating margin of 0.3%.

SOLV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Solventum Corp reported a net income of 63.00M and revenue of 2.00B, resulting in a net margin of 3.2%.

ELV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Elevance Health Inc reported a net income of 547.00M and revenue of 49.31B, resulting in a net margin of 1.1%.